Glycopyrrolate
NDC 16571-743, Glycopyrrolate, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-743
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA012827
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-743 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE1 mg/1
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-743-03 | 16571074303 | 30 TABLET in 1 CONTAINER (16571-743-03) |
| 16571-743-09 | 16571074309 | 90 TABLET in 1 CONTAINER (16571-743-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/58c4cb1f-59b8-4be9-a222-2264ca077d93NADAC price for package 16571074309
GET /v1/drugs/nadac/16571074309
Use it
Look up 16571-743 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-743 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-743. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.